In lung cancer, Tranilast inhibits TGF-β1-induced EMT and cell invasion by suppressing Smad4 expression, leading to reduced pleural dissemination of cancer cells (Takahashi et al., 2020). The gene discussed is SMAD4; the disease is cancer.